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1. Introduction 
Arguably, UV irradiation is one of the most relevant risk factors for the development of skin 
cancer, including basal and squamous cell carcinoma (SCC), and melanoma (Rigel, 2008). 
UV-induced DNA damage triggers specific genetic mutations in oncosuppressor genes 
and/or oncogenes that initiate downstream events for carcinogenesis (de Gruijl & Rebel, 
2008). It is increasingly clear that immunity plays a protective role in the detection and 
elimination of nascent tumors. This process termed “cancer immunosurveillance” has 
undergone a renaissance with the aid of elegant studies of cancer development in 
genetically engineered (targeting and/or transgenic) animals, and turned into the refined 
hypothesis termed “cancer immunoediting” (Vesely et al., 2011). UV radiation suppresses a 
variety of immune responses that contribute to carcinogenesis. The immunosuppressive 
effects of UV radiation may be involved in skin cancer development by impairing the 
antitumor immune responses that can destroy developing skin tumors. Moreover, UV 
radiation induces antigen-specific immune tolerance, which is largely mediated by 
regulatory T cells that specifically suppress immune responses against antigens expressed 
on emerging tumors (Katiyar, 2007). The temporal relationship between UV radiation and 
carcinogenesis revealed that UV radiation initiates tumor formation followed by 
suppression of immune responses specific to emerging tumors. Thus, the experiments 
documenting the immune suppressive effects of UV were conducted using naïve animals 
exposed to UV radiation prior to immunization. Accordingly, the prevailing notion of UV-
induced immune suppression places a supportive role of UV radiation for the initiation of 
tumor development. However, it is equally important to explore the possibility that UV 
radiation induces antigen-specific immune suppression in hosts that have established 
immunity toward corresponding antigen, since UV radiation may suppress anti-tumor 
immune responses against emerging skin tumors wherein UV radiation may play no 
causative roles but contributes to tumor progression. This notion of UV-induced 
immunosuppression contributing to the progression of already emerged tumors, has 
received less attention and is not well corroborated experimentally. It is important to note 
that some melanomas arise at sites such as palms, soles, and buttocks, which do not have 
obvious exposure to UV radiation. There is increasing concern for the decreasing 
stratospheric ozone levels that leads increase in exposure to short wave length UV-B 
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radiation on the terrestrial surface (Urbach, 1991). Therefore, it is incumbent upon us to gain 
a better understanding of the mechanisms of UV-induced immunosuppression involved in 
not only cancers wherein UV radiation plays a carcinogenic role but also those wherein it 
does not play an obvious causative role.  
Based on wavelength, UV light can be divided into three bands: UV-A (λ = 320–400 nm), 
UV-B (λ = 280–320 nm) and UV-C (λ = 200–280 nm) (Tyrrell, 1994). The stratospheric ozone 
layer absorbs UV-C and most of UV-B, resulting in the UV component of sunlight reaching 
terrestrial biosphere consists primarily of UV-A (95%) and UV-B (5%) (Diffey, 2002). The 
energy carried by each UV component is inversely related to its wavelength and thus UV-B 
has been historically deemed to be the major UV component in sunlight affecting human 
health. However, UV-A is the most abundant UV component in sunlight and penetrates 
deep into the skin, thus quantitatively equally effective in affecting human health. Therefore 
carcinogenic and immunosuppressive properties of UV-A and UV-B can be dealt without 
distiction. 
This chapter, in addition to presenting a comprehensive review of recent advances in the 
understanding of the causative roles of UV radiation in skin cancer development in the 
context of tumor immunology and the underlying cellular and molecular mechanisms 
involved, will also emphasize the notions of UV-induced immunosuppression contributing 
to the progression of already emerged tumors.  
2. UV-induced DNA damage results in the mutation of critical genes and the 
dysregulation of microRNA expression leading to malignant transformation 
Genome integrity in all living organisms is constantly threatened by endogenous and 
exogenous agents that modify the chemical integrity of DNA, collectively termed DNA 
damage, and in turn degenerate its informational contents (Wogan et al., 2004). If DNA 
damage is left unrepaired it can cause transcriptional silencing, proliferative arrest, and induce 
apoptosis (Hoeijmakers, 2001; Jackson & Bartek, 2009). To combat threats posed by DNA 
damage, cells are equipped with numerous mechanisms to detect and repair DNA lesions 
(Harper & Elledge, 2007; Harrison & Haber, 2006; Wood et al., 2005). Notwithstanding, some 
lesions remain in DNA during replication and are replicated in an error-prone manner 
resulting in mutations that enhance cancer risk (Jacinto & Esteller, 2007; Livneh, 2006). The 
most pervasive environmental DNA-damaging agent is UV radiation, and this is the primary 
basis for the carcinogenic properties of UV radiation. The International Agency for Research 
on Cancer published a monograph providing evidence for the carcinogenic properties of UV 
radiation in sunlight in 1992 (IARC, 1992) and now classifies UV radiation as a human 
carcinogen (http://monographs.iarc.fr/ENG/Classification/index.php). UV-induced DNA 
damage initiates a chain of events leading to carcinogenesis, collectively termed as 
“photocarcinogenesis”. This process involves the formation of mutations at sites of DNA 
damage and, ultimately, results in malignant transformation after the accumulation of a 
sufficient number of mutations in critical genes (Runger, 2007). These mutations can occur in 
tumor suppressor genes such as p53 (Brash et al., 1991; Hussein et al., 2003; Rees, 1994; Ziegler 
et al., 1994; Ziegler et al., 1993), CDKN2/p16 (Holly et al., 1995; Saridaki et al., 2003; Soufir et al., 
1999; Sparrow et al., 1998), and PTCH (D'Errico et al., 2000; Daya-Grosjean & Sarasin, 2000; de 
Gruijl et al., 2001; Ping et al., 2001; Zhang et al., 2001) as well as proto-oncogenes such as RAS 
(Chan et al., 2002; Kreimer-Erlacher et al., 2001; Spencer et al., 1995; van der Schroeff et al., 
1990) and RAF (Besaratinia & Pfeifer, 2008; Gaddameedhi et al., 2010). UV-induced DNA 
damage also induces transcriptional activation of proto-oncogene c-fos (Ghosh et al., 1993).  
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2.1 DNA damage 
The heterocyclic bases of DNA efficiently absorb energy in the UV that results in DNA 
lesions through a photochemical reaction (Ely & Ross, 1949). Thus the efficiency and the 
type of DNA lesion formation depends on the wavelength, peaking between 260 nm and 265 
nm within the UV-B region (Markovitsi et al., 2010). The predominant form of DNA lesions 
are cyclobutane pyrimidine dimers (CPDs) and pyrimidine 6-4 pyrimidone photoproducts 
(6-4PPs), which constitute 65% and 35% of UV-B-induced DNA lesions, respectively (Lippke 
et al., 1981; Mitchell et al., 1992). Although direct absorption of photon energy by DNA is 
extremely low at the UV-A region, recent studies show that UV-A also triggers DNA-
damage via formation of CPDs (Mouret et al., 2006; Rochette et al., 2003). Furthermore, UV-
A induces conversion of 6-4PPs into an isomeric secondary product, Dewar valence isomer 
(Douki et al., 2003; Perdiz et al., 2000). It has been estimated that strong sunlight can induce 
approximately 100,000 lesions per cell exposed per hour (Jackson & Bartek, 2009). CPDs, 6-
4PPs and Dewar valence isomers are induced by natural sunlight in normal human 
mononuclear cells (Clingen et al., 1995), and result in UV-specific mutations. These 
photolesions are highly mutagenic because of error-prone repair that results in thymidine 
substitutions. Although the contribution of 6-4PPs to UV-induced carcinogenesis has been 
elusive (Jans et al., 2006), the causative role of CPDs in UV-induced carcinogenesis was 
substantiated by specific removal of these DNA lesions through DNA repair enzymes 
leading to significantly reduced risk of UV-induced skin cancer in mice (Jans et al., 2005) 
and human (Yarosh et al., 1992; Yarosh et al., 2001). Besides the formation of DNA-lesions, 
cis-urocanic acid (cis-UCA) is formed from its isomer trans-UCA, which is abundant in skin 
exposed to UV radiation. A recent study showed direct evidence that cis-UCA induces 
reactive oxygen species (ROS) (Sreevidya et al., 2010) that leads the oxidative base 
modifications, predominantly at guanine base, and to the generation of the mutagenic DNA 
lesion, 8-oxo-7,8-dihydor-2’-deoxyguanosine (8-oxo-dG) (Douki et al., 1999; Kielbassa et al., 
1997; Zhang et al., 1997). All these lesions are assumed to contribute to the generation of p53 
mutations in SCC (Brash et al., 1991; Ziegler et al., 1994), Ras mutations in melanoma 
(Jiveskog et al., 1998), and p16 in actinic keratosis (Kanellou et al., 2008).  
2.2 microRNAs 
Recent studies implicate a small non-coding RNA species, microRNA, as a new player in the 
field of UV-induced carcinogenesis. microRNAs have important regulatory roles in diverse 
cellular pathways through their association with 3’-untranslated region of target mRNAs 
(Bartel, 2004). Increasing evidence indicates that DNA damage induced by UV irradiation 
provokes profound changes in expression of microRNAs (Pothof et al., 2009). Enlightening 
findings on the microRNA expression profile have been obtained in mouse fibroblast cell 
line NIH3T3 irradiated with UV-B. UV-B irradiation resulted in robust changes in the 
microRNA expression profile including the upregulation of let-7a, miR-21, and miR-24 and 
the downregulation of miR-465 (Guo et al., 2009). Subsequent work on microRNA 
expression in primary human keratinocytes exposed to UV-A or UV-B radiation revealed 
that UV-A induces miR-21, miR-203, and miR-205, whereas UV-B moderately induces  
miR-203, reduces miR-205 and had no effect on miR-21 (Dziunycz et al., 2010). Of particular 
interest is the observation that UV-A, but not UV-B, increased the expression of miR-21, 
since UV-A is responsible for SCC formation to a much higher extent than UV-B (Dziunycz 
et al., 2010). miR-21 is one of the most studied microRNAs and has potent carcinogenic 
properties (Selcuklu et al., 2009). It is currently well recognized that UVR induces aberrant 
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microRNA expression in response to DNA damage. As aberrant microRNA expression has 
been observed in a variety of cancers (Catto et al., 2011; Selcuklu et al., 2009), the 
carcinogenic property of UV through DNA-lesion formation may also involve microRNA 
misexpression. Therefore, UV-induced DNA-lesion that directly causes mutations in critical 
oncogenes, tumor suppressor genes, or transcriptional regulatory regions of these genes, 
and UV-mediated modification of microRNA expression may collaboratively induce 
malignant transformation.  
Arguably, cells are equipped with a variety of intrinsic tumor-suppressor mechanisms that 
attempt to repair genetic mutations and trigger senescence or apoptosis in order to prevent 
transformation. Normal cells can be transformed into tumor cells by the combination of 
genetic mutation and failed intrinsic tumor-suppressor mechanisms. However, emerging 
transformed cells and precancerous cells are usually kept in check by the host immune 
system, which acts as an extrinsic tumor suppressor mechanism that senses the presence of 
cancerous cells and restricts their growth. In the following section, the concept of tumor 
immunosurveillance and its updated hypothesis of tumor immunoediting, as well as the 
mechanisms by which UV irradiation interferes with these processes to promote 
tumorigenesis will be explored.  
3. UV radiation suppresses the host immune system ability to eliminate 
emerging transformed cells 
3.1 Cancer immunoediting 
The relative contribution of the immune system to the control of cancer development and 
growth has been debated for many years. It was not until 2010 that Hanahan and Weinberg 
reviewed “immunity” as an emerging hallmark of cancer (Hanahan & Weinberg, 2011) 
expanded beyond their previous landmark review (Hanahan & Weinberg, 2000), from 
which immunity was notably absent. Now, there is ample evidence supporting a protective 
role for immunity in the detection and elimination of nascent tumors. This process called 
“cancer immunosurveillance”, originally conceived in 1909 by Paul Ehrlich and later 
hypothesized by Burnet and Thomas in the late 1950s, has undergone a renaissance with 
elegant studies of cancer development in genetically engineered (targeting and/or 
transgenic) animals, which have helped spawn the notion of “cancer immunoediting”. 
Cancer immunoediting proposes that cancer development and growth are controlled by 
three sequential phases: elimination, equilibrium, and escape. The elimination phase of 
cancer immunoediting is equivalent to the process described in the original hypothesis of 
immunosurveillance, whereby innate and adaptive immunity collaborate to detect and 
eliminate tumor cells that have developed as a result of failed intrinsic tumor suppressor 
mechanisms mentioned previously. In instances in which tumor cell destruction goes to 
completion, the elimination phase represents an endpoint of cancer immunoediting. 
However, rare tumor cell variants may survive in the elimination phase, leading to an 
equilibrium state between host immune system and developing tumors. In this equilibrium 
phase, the host immune system controls net tumor cell outgrowth, which results in the 
tumor cells remaining functionally dormant, but also sculpts the immunogenicity of the 
tumor cells. During this phase, T cell-mediated adaptive immunity exerts potent and 
relentless selection pressure on the tumor cells that is enough to contain but not fully 
extinguish the tumor bed containing many genetically unstable and mutating tumor cells, 
which can be viewed as a crucible of Darwinian selection. This phase can last for the life of 
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the host, in which case the host does not develop any clinical manifestations and the 
equilibrium phase represents the second stable endpoint of cancer immunoediting. 
However, the constant immune selection pressure placed on genetically unstable tumor cells 
may lead to the emergence of tumor cell variants with any of the following characteristics: 
(i) invisible to adaptive immunity (variants with antigen loss or defect in antigen processing 
or presentation), (ii) insensitive to immune effector mechanisms, and (iii) ability to induce 
an immunosuppressive state within the tumor microenvironment, collectively referred low-
immunogenic tumor variants. Therefore, although many of the original tumor cells that 
have survived in the elimination phase are destroyed, new variants arise that carry different 
mutations and altered gene expression profiles which endow them with the means to 
subvert immune-mediated recognition and destruction. Moreover, the growth of the 
selected variants is no longer controlled by immune system, leading to the appearance of 
overt cancer in the escape phase. In the escape phase, tumor cells that have acquired the 
ability to circumvent immune recognition or destruction emerge as progressively growing 
tumors and induce various clinical manifestations.  
Evidence in support of the process of immunoediting comes mainly from mouse studies 
comparing the properties of tumors induced by chemical carcinogens in animals that are 
either immunocompetent or immunodeficient; however, increasing clinical observations 
have also provided evidence supporting the notion of tumor immunoediting in humans. In 
mice, immunodeficient mice develop more tumors, more rapidly, and at lower chemical 
carcinogen doses than wild-type immunocompetent mice (Dighe et al., 1994; Kaplan et al., 
1998; Shankaran et al., 2001; Smyth et al., 2001; Street et al., 2001; Street et al., 2002). 
Immunodeficient mice also display an increased incidence of disseminated lymphomas or 
spontaneous lung adenocarcinomas, depending on mouse strains. Furthermore, tumors cell 
lines derived from immunocompetent mice survive well in both immunocompetent and 
immunodeficient mice upon transplantation, whereas those derived from immunodeficient 
mice survive only in immunodeficient mice and are easily rejected in immunocompetent 
mice, indicating that tumors developed in immunocompetent mice are edited to be less 
immunogenic. In humans, patients with AIDS and organ transplantation recipients that 
have received immunosuppressants have increased frequencies of malignancies. Although 
virus-associated malignancies predominate and thus an argument can be made that the 
increased frequency of virus-associated cancers reflects a breakdown in antiviral immunity 
rather than reduced immunosurveillance of cancer, these is also an increased risks for the 
development of noninfectious cancers (Boshoff & Weiss, 2002; Chaturvedi et al., 2007; Frisch 
et al., 2001; Vajdic et al., 2006). In relation to skin cancer, a 200-fold increased risk of 
nonmelanoma skin cancers and 2- to 10-fold increased frequency of melanomas have been 
reported in renal transplant patients (Moloney et al., 2006). Patients with liver transplants 
also manifest a greater preponderance of nonmelanoma skin cancers (Aberg et al., 2008). 
Furthermore, there is a direct correlation between the duration of immunosuppressant 
administration and the incidence of cancer development (Loeffelbein et al., 2009), 
supporting the existence of human cancer immunosurveillance.  
Most of the observations that the immunosuppressive status of the host may promote tumor 
development and growth largely recapitulate the studies conducted in UV-irradiated mice, 
in which the pioneering work of Fisher and Kripke established the field of 
photoimmunology, involving elements of photobiology, immunology, and oncology (Fisher 
& Kripke, 1977). In the following sections, we will deal with UV-induced immune 
suppression that supports tumor development and progression.  
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3.2 UV radiation suppresses anti-tumor immunity and promotes tumor development 
The first clear evidence that UV irradiation can affect immune responses emanated from the 
seminal work of Margaret Kripke and her colleagues in the 1970’s, who demonstrated that 
skin tumors induced by chronic exposure to UV radiation were highly immunogenic, as 
they were rejected when transplanted into age- and sex-matched healthy syngeneic mice. In 
hindsight, the tumors developed in UV-irradiated hosts were not edited. They further 
showed that prior exposure of recipient mice to subcarcinogenic doses of UV-B resulted in 
the acceptance of the transplanted tumors, clearly indicating that UV systemically 
suppresses host immunity against tumors (DeFabo & Kripke, 1979; Fisher & Kripke, 1977; 
Kripke, 1974). Tumors were accepted even when transplanted into sites not directly exposed 
to UV radiation, indicating that UV radiation exerts systemic immunosuppression (DeFabo 
& Kripke, 1979; Fisher & Kripke, 1977). The effect of UV on the acceptance of the 
transplanted tumors was shown to be UV dose-dependent. In another study in primary 
tumor development model using UV independently as an immunosuppressant and a tumor 
initiator, de Gruijl et al. demonstrated the immunosuppressive effect of UV via the 
inhibition of cancer immunosurveillance leading to the acceleration of tumorigenesis (de 
Gruiji & van der Leun, 1982; de Gruijl & Van Der Leun, 1983). In these studies, hairless mice 
were pre-irradiated with UV radiation while certain skin areas of the animals were shielded 
from the radiation. Pre-irradiation was carried out to the point where tumors started to 
appear in the pre-irradiation skin areas (13 weeks). Then, the initially shielded skin areas 
were chronically exposed to UV radiation, which resulted in the development of tumors in 
these skin areas. They demonstrated that the formation of tumors in the initially shielded 
skin areas was enhanced by the pre-irradiation of the other skin areas. Subsequently, they 
also showed that the formation of tumors in initially shielded skin areas was still enhanced 
even when the pre-irradiation was discontinued long before the appearance of tumor in pre-
irradiated skin areas. These earlier studies revealed that UV irradiation disturbs cancer 
immunosurveillance, leading to the accelerated development of tumors and the emergence 
of highly immunogenic (non-edited) tumors. Collectively, these results indicate that UV-B 
radiation has a dual effect on skin carcinogenesis, not only as an inducer, but also as a 
promoter. Subsequent studies utilizing models of contact hypersensitivity (CHS), wherein 
mice were sensitized by epicutaneous application of contact allergens induced an ear 
swelling response, recapitulated the immunosuppressive features of UV radiation seen in 
skin carcinogenesis (Noonan et al., 1981; Toews et al., 1980). In these studies, mice sensitized 
with a hapten to the skin that had been exposed to UV-defected CHS responses (Toews et 
al., 1980). Furthermore, these mice exhibited systemic and long-term unresponsiveness to 
the same hapten, since the mice could not be re-sensitized against the same hapten at a later 
time point even when the hapten was applied to skin not previously exposed to UV. This 
unresponsiveness was antigen-specific, since the mice exhibited normal CHS responses 
against other unrelated haptens. These studies unravel important features of UV-induced 
immunosuppression, particularly long-lasting and antigen specific immune responses. 
3.3 Regulatory T cells are responsible for the UV-induced suppression of anti-tumor 
immunity 
Early work on UV-induced immunosuppression by Kripke and colleagues revealed that 
UV-B induced immunosuppression was transferable by adoptive transfer of lymphocytes 
from irradiated mice into non-irradiated mice (Fisher & Kripke, 1977; Hostetler et al., 1989; 
Kripke & Fisher, 1976; Kripke et al., 1977; Kripke et al., 1979; Roberts et al., 1982; Spellman & 
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Daynes, 1977; Spellman & Daynes, 1984; Spellman et al., 1977; Ullrich & Kripke, 1984). In 
these studies, recipient mice infused with T cells from UV-irradiated mice were unable to 
reject UV-induced tumors (Fisher & Kripke, 1977; Kripke & Fisher, 1976; Kripke et al., 1977; 
Spellman & Daynes, 1977; Spellman et al., 1977), but not non-UV-induced tumors such as 
tumors induced by chemical carcinogen (Hostetler et al., 1989; Kripke et al., 1979; Roberts et 
al., 1982; Spellman & Daynes, 1984; Ullrich & Kripke, 1984), suggesting some degree of 
antigen-specificity. Subsequent studies using a CHS model further delineated antigen-
specific immune suppression by T cells from UV-irradiated hosts. Upon adoptive transfer 
with T cells obtained from mice that had been treated with a hapten onto UV-exposed skin, 
the recipient mice were no-longer responsive to the very same hapten; however, these 
recipient mice could respond normally to other unrelated haptens (Elmets et al., 1983). 
These results convincingly demonstrated that T cells mediate UV-induced 
immunosuppression in an antigen-specific manner. Consequently, these T cells were 
designated as suppressor T cells, and have since been renamed regulatory T cells (Beissert et 
al., 2006). Even then these early experiments suggested that variations in these regulatory T 
cell populations might exist depending on the experimental systems used to induce and 
examine the UV-induced immunosuppression. Although the lack of clear markers that 
define a specific subset of T cells still impedes the attempts to fully characterize UV-induced 
regulatory T cells, recent studies have demonstrated that UV-induced regulatory T cells 
include CD3+DX5+ NKT cells (Moodycliffe et al., 2000); CD4+CD25+ T cells co-expressing 
CTLA-4, GITR, and neuropilin-1 (Maeda et al., 2008); CD4+Foxp3+ T cells (Ghoreishi & Dutz, 
2006; Loser et al., 2006); and type 1 regulatory T cells (Hori et al., 2008; Toda et al., 2010; 
Wang et al., 2010; Wang et al., 2008).  
NK-T cells. The CD1d molecules are structurally similar to MHC class I molecules that 
presents lipid antigens to NKT cells (Brigl & Brenner, 2004). Moodycliffe et al. have 
demonstrated that CD1d-deficient mice are resistant to UV-induced immune suppression 
(Moodycliffe et al., 2000). Adoptive transfer of a purified population of CD3+DX5+ NKT cells 
from UV-irradiated wild-type mice, which produced high amount of IL-4, into normal 
syngeneic mice suppressed antigen-specific delayed type hypersensitivity and anti-tumor 
immune responses against transplanted highly immunogenic UV-induced skin tumors. 
Subsequent study also revealed that CD1d-deficient mice are resistant to UV-induced skin 
carcinogenesis (Matsumura et al., 2005). Although, the observed resistant characteristics of 
CD1d-deficient mice to UV-induced skin carcinogenesis may not be solely due to the lack of 
NKT cells, these results indicate that UV irradiation induced immunosuppressive NKT cells 
that may promote tumor development. Recently, it has been shown that epidermal 
Langerhans cells (LCs) are responsible for the induction of immunosuppressive NKT cell by 
UV radiation (Fukunaga et al., 2010). UV radiation activates migration of LCs to the skin 
draining lymph nodes. Adoptive transfer of LCs from the lymph node of UV-irradiated 
mice into wild-type mice, but not CD1d-deficient mice, resulted in antigen-specific 
immunosuppression. This study highlights the recent notion that LCs may not play a major 
role in cutaneous immune responses, but rather regulate immunity in infection and CHS, 
and play an important role in UV-induced immunosuppression. It has been well 
documented that the immunosuppressive mechanisms of action of NKT cells remains less 
clear, but appears to be dependent on IL-4, since immune suppression in mice transferred 
with LCs from UV-irradiated mice were completely blocked by neutralization of IL-4. 
However, how NKT cells in UV-irradiated host suppress anti-tumor immune responses 
remain largely unknown.  
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 regulatory T cells. It was not until 1985 that Sakaguchi et al. resurrected the 
suppressor T cells, now renamed regulatory T cells, following almost two decades of 
abandonment in the field of immunology (Sakaguchi et al., 2007). First characterization of 
this T cell subset revealed that they constitutively expressed CD25 and suppressed 
autoimmunity. The current explosive developments in the field of regulatory T cells have 
shown that CD25+CD4+ regulatory T cells express the cell surface molecules such as CTLA-
4, neurophilin-1, and folate receptor, and Foxp3 transcription factor. The findings at the 
cellular and molecular levels altogether provide firm evidence for their crucial roles in the 
establishment and maintenance of immunologic self-tolerance and immune homeostasis 
(Sakaguchi et al., 2007). Furthermore, it is increasingly clear that CD25+CD4+Foxp3+ 
regulatory T cells play an important role in the suppression of anti-tumor immune 
responses (Nishikawa et al., 2008; Nishikawa et al., 2003; Nishikawa et al., 2005; Nishikawa 
et al., 2005). Importantly, we have shown that CD25+CD4+Foxp3+ regulatory T cells 
significantly accelerate tumor development in a chemical carcinogen-induced primary 
tumor development model (Nishikawa et al., 2005). Recent studies revealed that 
CD25+CD4+Foxp3+ regulatory T cells were also involved in the UV-induced 
immunosuppression. Loser et al. have demonstrated that receptor activator of NF-B 
(RANK) and its ligand, RANKL, were involved in UV-induced immunosuppression via 
activation and/or expansion of CD25+CD4+Foxp3+ regulatory T cells (Loser et al., 2006). 
They showed that UV irradiation induced the expression of RANKL on basal keratinocytes. 
Injection of specific RANKL antagonist, RANK-Fc, followed by UV irradiation and hapten 
immunization resulted in the abrogation of UV-induced hapten-specific immune 
suppression. Finally, it was found that RANK–RANKL signaling between RANK-
expressing LCs and RANKL-overexpressing keratinocytes driven by K14 promoter 
transgenic mice resulted in the increased capacity of LCs to stimulate the proliferation of 
CD25+CD4+Foxp3+ regulatory T cells. LCs stimulated by RANKL exhibit elevated 
expression of DEC205 and CD86 as well as increased IL-10 secretion, all of which have been 
shown to be associated with the DC-induced expansion of regulatory T cells (Loser et al., 
2006; Mahnke et al., 2003; Maurer et al., 2003).  In the study of Ghoreishi et al., 
transcutaneous immunization through UV-irradiated skin induced an increase in 
CD25+CD4+Foxp3+ regulatory T cells that suppressed CTL responses against tumors 
(Ghoreishi & Dutz, 2006). In this study, IL-10 was not required for the induction and 
suppressive function of CD25+CD4+Foxp3+ regulatory T cells. Such T cells were induced in 
IL-10-deficient mice and these regulatory T cells conferred suppression of immune 
responses upon transfer into IL-10-sufficient, but not IL-10-deficient mice. Therefore, it is 
suggested that UV-irradiation induces CD25+CD4+Foxp3+ regulatory T cells independently 
of IL-10 expression, but these UV-induced regulatory T cells require IL-10 derived from 
other type of cells, in order to mediate anti-tumor immune responses and support tumor 
development in UV-irradiated hosts.       
IL-10 producing regulatory T cells. Schwarz and colleagues have conducted a series of 
studies to characterize UV-induced regulatory T cells using a CHS model. In their studies, 
UV-induced regulatory T cells that confer suppression of CHS belong to the CD4+CD25+ 
subtype (Schwarz et al., 2004); co-express CTLA-4, GITR, and neuropilin-1 (Maeda et al., 
2008; Schwarz et al., 2000); and bind the lectin dectin-2 (Aragane et al., 2003). While most of 
these phenotypic features are similar to CD25+CD4+Foxp3+ regulatory T cells, these UV-
induced regulatory T cells produced large amounts of IL-10 that mediates 
immunosuppression. Additionally, these UV-induced regulatory T cells exerted bystander 
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suppression via the release of IL-10. These characteristics collectively indicate that this 
regulatory T cell subset belongs to Tr1 originally described by Groux et al. (Groux et al., 
1997; Roncarolo et al., 2006; Vieira et al., 2004). The same group has also demonstrated that 
IL-10 negatively regulates CTL responses in UV-irradiated mice, which was associated with 
enhanced tumor growth (Loser et al., 2007). CD4+CD25+ T cells from UV-irradiated wild-
type mice, but not those from UV-irradiated IL-10 deficient mice, could transfer the 
suppression of anti-tumor immune responses (Loser et al., 2007). Therefore, it is highly 
likely that UV-induced regulatory T cells reported by Schwarz et al. may also promote 
tumor development through production of IL-10. It appears that LCs with DNA-damage 
play an important role in the induction of this type of UV-induced regulatory T cells, since 
reduction of LCs containing CPDs in the regional lymph nodes by IL-12 prevented the 
development of UV-induced regulatory T cells. The effect of IL-12 on the prevention of UV-
induced regulatory T cell development was not seen in mice deficient for DNA-repair 
enzymes. 
4. UV radiation may induce tumor antigen-specific immune suppression thus 
contributing to the progression of emerging tumors 
In most studies dealing with UV-induced immunosuppression and its impact on anti-tumor 
immunity, hosts are exposed to UV radiation before immunization, and only a few studies 
have examined the effect of UV irradiation on established immune responses (Nghiem et al., 
2001; Nghiem et al., 2002; Ullrich et al., 2007). Based on the potent immunosuppressive 
effects of UV irradiation on a variety of immune responses, there is a high likelihood that it 
affects the efficacy of immune protection afforded by prior vaccination but may also provide 
tools to develop new therapies for allergic diseases and transplantation. Furthermore, it is 
also possible that exposure to UV radiation in hosts whose immunity is successfully 
controlling benign or premalignant tumors may induce tumor-specific immunosuppression 
and contribute to the development of clinically apparent tumors.  In a series of studies, we 
have demonstrated that mice exposed to UV radiation one week after immunization 
exhibited reduced Th1- and Th2-driven Ab responses, suppressed airway inflammation in 
sensitized mice, and prolonged allograft survival in an Ag-specific manner (Hori et al., 2008; 
Wang et al., 2010; Wang et al., 2008). Additionally, we showed that UV irradiation following 
immunization led to the generation of CD4+ regulatory T cells producing IL-10 and IFN-, 
and Ag-dependent secretion of IL-10 was responsible for the immunosuppression. These 
phenotypic and functional features were reminiscent of Tr1. However, CD4 T cells from 
UV-irradiated mice contained Foxp3 T cells lacking IL-10 expression (Wang et al., 2008). 
Recently, we generated a panel of T cell clones from UV-irradiated mice and examined their 
functional and phenotypic characteristics to better characterize the immunosuppressive 
cells. All of the T cell clones derived from UV-irradiated mice produced both IL-10 and IFN-
, but not IL-4, and this strongly argues that a general shift of immunity from a Th1- to Th2-
type immune response is not responsible for the UV-induced immune suppression (Beissert 
et al., 1996; Shreedhar et al., 1998). Notably, the T cell clones derived from UV-irradiated 
mice lacked expression of Foxp3 mRNA, but they uniformly expressed c-Maf mRNA. c-Maf 
was originally described as a Th2-specific transcription factor, but subsequent studies 
revealed that c-Maf transactivates IL-10 gene transcription independently of Th2 
differentiation (Cao et al., 2005; Xu et al., 2009). More recent studies indicate that c-Maf 
transactivates IL-21, which acts as an autocrine growth factor for the expansion and/or 
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maintenance of Tr1 cells (Apetoh et al., 2010; Pot et al., 2009). Although Th2 cells express c-
Maf, it has also been shown that the expression levels of c-Maf mRNA are ~500-fold higher 
in Tr1 cells compared to Th2 cells (Pot et al., 2009). Therefore, c-Maf now can be regarded as 
a critical transcription factor for Tr1 cells. In addition, T cell clones from UV-irradiated mice 
exerted Ag-specific and bystander suppression of T cell activation in an IL-10-dependent but 
a contact-independent fashion. Taken together, these results indicate that UV-induced 
regulatory T cell subsets involve Tr1. We also found that IL-10 was required for the 
development of this regulatory T cell subset. CD4+ T cells from UV-irradiated mice treated 
with anti-IL-10 no longer have immunosuppressive properties, clearly indicating that IL-10 
is necessary for UV-induced regulatory T cells. Consistent with others, IL-10 is detectable in 
serum of mice exposed to UV radiation at dose of 15 or 30 kJ/m2 (Beissert et al., 1996; Rivas 
& Ullrich, 1994; Shreedhar et al., 1998). In addition, treating UV-irradiated mice with anti-IL-
10 has been reported to block the induction of systemic immune suppression (Rivas & 
Ullrich, 1992), which substantiates our results that neutralization of IL-10 suppresses the 
generation and function of regulatory T cells induced by UV-irradiation. Therefore, IL-10 
that was possibly secreted by keratinocytes upon UV-irradiation (Rivas & Ullrich, 1992) 
appeared to play an obligatory role in the generation of Tr1-like regulatory T cells that 
mediated suppression of variety of immune responses. Although the precise mechanism by 
which UV induces Tr1-like regulatory T cells in vivo remains elusive, our preliminary 
experiments indicated that the effect of IL-10 induced by UV-irradiation on the generation of 
Tr1-like regulatory T cells was not a direct effect on T cells, because repetitive stimulation of 
CD4+ T cells by anti-CD3 together with IL-10 in the presence, but not absence, of APC 
resulted in the generation of IL-10 producing Tr1-like regulatory T cells in vitro. These 
results confirm previous studies showing that IL-10 modulates APC and/or induces 
differentiation of CD11clowCD45RBhigh DCs required to induce the generation of Tr1 in vitro 
and in vivo (Wakkach et al., 2001; Wakkach et al., 2003). However, it remains elusive 
whether UV induces such phenotypic changes or generation of such DCs. Importantly, 
using a murine tumor model in which ovalbumin (OVA) served as a surrogate tumor Ag, 
we demonstrated that exposure to UV radiation in OVA-immunized mice significantly 
accelerated the acceptance of the tumor as compared to those exposed to UV radiation 
alone, which is mediated antigen-specific regulatory T cells mentioned above. We also 
showed that these regulatory T cells suppress the induction and/or activation of cytotoxic T 
cells. All these results indicate that UV-irradiation after immunization induces Tr1 cells 
specific to the immunizing Ag and dominantly suppresses a variety of immune responses 
that control tumor progression. Accumulating evidence indicates that precancerous and 
malignant cells can induce specific immune response that leads to the elimination of 
malignant and/or transformed cell before they developed detectable tumors. Furthermore, 
recent multivariate analysis of a multi-country ecological study and population based, case-
control study have shown a significant positive association between exposure to UV 
radiation and increase in the risks of non-Hodgkin’s lymphoma and colon cancer, in 
addition to skin melanoma (Waltz & Chodick, 2008; Zhang et al., 2007). Even in the case 
with melanomas, some melanomas arise at such as palms, soles, and mucosal surfaces, 
which do not have obvious exposure to UV (Garibyan & Fisher, 2010). Therefore, it appears 
plausible that exposure to UV radiation in hosts whose immunity successfully controlling 
benign or premalignant tumors induces tumor-specific immunosuppression and contributes 
to tumor progression. In this regard, UV-induced immune suppression may also play an 
important role in the progression of various tumors, including some in which UV radiation 
does not play a direct causative role. 
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5. Molecules that trigger UV-induced immunosuppression 
Immunologic reactions are evoked by an intricate network of signaling and cell activation. 
Therefore, UV-induced immunosuppression may also have evolved under the influence of 
altered molecules expressed in cells damaged by UV radiation. As is the case with a major 
role of DNA-damage played in the initiation of carcinogenesis, accumulating evidence 
indicates that UV-induced DNA-damage is an important trigger for UV-induced 
immunosuppression. The topical application of exogenous DNA repair enzymes to UV-
irradiated skin has been shown to reduce UV-induced DNA-damage and resulted in the 
abrogation of UV-induced immunosuppression (Applegate et al., 1989; Kripke et al., 1992). 
Consistent with this finding, it has been shown that DNA-damage induced by the treatment 
of mice with HindIII-containing liposomes causes double-strand breaks and induces 
immunosuppression (Nishigori et al., 1998). Likewise, deficiency in DNA repair in XPA 
(xeroderma pigmentosum group A)-gene knockout mice exhibits enhanced susceptibility to 
UV-induced immunosuppression (Miyauchi-Hashimoto et al., 1996). IL-12 was the first 
cytokine being demonstrated to exert the capacity to prevent UV-induced 
immunosuppression (Muller et al., 1995; Schmitt et al., 1995; Schwarz et al., 1996). Because of 
its well-recognized immunostimulatory activities (Trinchieri, 2003), it was no wonder that 
exogenous administration of IL-12 recovered the immunosuppressive effects of UV 
radiation. However, recent studies unravel an unexpected capacity of IL-12 to reduce DNA-
damage via induction or activation of the nucleotide excision repair (NER), the major 
endogenous DNA repair system (Schwarz et al., 2002). It has been demonstrated that IL-12 
is unable to prevent UV-induced immunosuppression in mice deficient for NER (Schwarz et 
al., 2005). Using mouse models, the additional factors that influence the NER and reverse 
UV-induced immunosuppression have been demonstrated, including IL-18 (Schwarz et al., 
2006), IL-23 (Majewski et al.), α-melanocyte-stimulating hormone (Bohm et al., 2005), 
infrared radiation (Jantschitsch et al., 2009), vitamin D (Tremezaygues et al., 2009), and even 
UV-A (Garssen et al., 2001) possibly through the induction of IL-12 (Shen et al., 1999); 
however, their relevance in human subjects remains to be determined. Although UV 
radiation induces different types of DNA lesions such as CPDs and 6-4PPs along with its 
isomeric secondary product, Dewar valence isomer, it was later found that repair of 6-4PPs 
had no effect on UV-induced immunosuppression (Jans et al., 2006). Using mice expressing 
the P. tridacylus CPD photolylase enzyme under the control of the basal keratinocyte-specific 
promoter keratin-14, which allows rapid, light-dependent removal of CPDs from basal 
keratinocytes only, it was demonstrated that removal of CPDs solely from basal epidermal 
cells in transgenic mice resulted in a major reduction in UV-induced carcinogenesis, but did 
not reverse UV-induced immunosuppression, whereas the removal from the entire skin 
reversed UV-induced immunosuppression (Jans et al., 2006). UV-induced DNA-damage in 
different cell types independently mediates carcinogenic or immunosuppressive properties 
of UV radiation. Collectively, these studies convincingly demonstrate that DNA-damage, 
especially in the form of CPDs, is a major molecular trigger in UV-induced 
immunosuppression.  
In addition to CPDs, UV radiation induces the formation of cis-urocanic acid (cis-UCA) from 
its isomer trans-UCA. Trans-UCA is abundant in the skin because of the lack of the 
necessary enzymes in epidermal cells to catabolize UCA generated in the metabolic 
pathway of the essential amino acid histidine. Injection of cis-UCA (Beissert et al., 1997; De 
Fabo & Noonan, 1983; Norval et al., 1995) induces immunosuppression, whereas its removal 
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by epidermal stripping, neutralization by antibodies, or blocking the binding to its receptor 
(5-HT2A) with selective serotonin receptor antagonists, restores immune suppression 
induced by UV radiation (De Fabo & Noonan, 1983; Moodycliffe et al., 1996; Walterscheid et 
al., 2006). It also has been shown that neutralization of cis-UCA in vivo suppressed UV-
induced carcinogenesis (Beissert et al., 2001). Despite all these documented abilities of cis-
UCA to influence immune suppression and carcinogenesis, recent studies demonstrated that 
cis-UCA induces apoptosis in several human tumor cells including melanomas (Laihia et al., 
2010; Laihia et al., 2009; Peuhu et al., 2010), and cis-UCA has been recognized as a potential 
anti-cancer agent.  
Nevertheless, CPDs and cis-UCA, abundant molecules in UV-irradiated skin, are 
responsible for UV-induced immunosuppression. These molecules have been shown to 
induce cytokines such as IL-10, PGE2, and TGF- (Curiel-Lewandrowski et al., 2003; Grewe 
et al., 2000; Kaneko et al., 2008; Kaneko et al., 2009; Nishigori et al., 1996), all of which may 
be involved in the development and/or activation of cells with regulatory activities (Allan et 
al., 2008). However, what still remains elusive is how these molecules induce various types 
of regulatory T cells that mediate antigen-specific and systemic immunosuppression. 
6. Conclusion 
Over the decades, it has become clear that UV irradiation has the potential to suppress a 
variety of immune reactions including anti-tumor immune responses through the 
generation of antigen-specific regulatory T cells. The concepts of ‘regulatory T cells’ and 
‘immune control of tumor’ have experienced a very eventful past having been dogmatically 
disregarded and abandoned but being now highly appreciated and well recognized by the 
majority of immunologists. Major credit can be given to the researchers in the field of 
photoimmunology who persistently pursued and accumulated evidence supporting both 
concepts. However, it seems that the importance or physiological relevance of UV-induced 
skin cancers, wherein the existence of cancer immunity and regulatory T cells are so 
obvious, has never been established as a prominent model in the field of tumor immunology 
and immunology in general. As may be seen in this chapter, it is now quite clear that UV 
radiation plays an indisputable role in skin carcinogenesis, as a tumor initiator and 
progressor, and also in the development of cancer wherein UV radiation does not play a 
causative role.  
Recent studies have begun to unravel the differential effects of UV radiation on the innate 
and the adaptive immune system (Schwarz, 2010). Although UV irradiation clearly 
suppresses adaptive immunity, it may activate innate immunity. It has been shown that 
only 30–50% of UVR doses that induced detectable sunburn are required for the suppression 
of immunity in humans, and therefore normal daily outdoor activities are likely to cause 
some degree of immunosuppression. Understanding that the skin is an organ that seems 
quite prone to autoimmunity, it is plausible that a certain degree of immunosuppression by 
daily solar exposure may be protective against autoimmunity, and that activation of innate 
immunity may compensate for the increased risks of microbial infection by suppression of 
adaptive immunity, which may function as a part of the protection mechanism acquired 
during evolution. This may argue against total sun protection for the sake of skin cancer 
prevention. Additionally, patients with allergic diseases that also receive benefit from UV-
phototherapy may be through the induction of regulatory T cells (Wang, 2010). Thus, 
despite the fact that excessive and chronic UV radiation exposure remains one of the major 
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environmental threats for human health, a better understanding of carcinogenic and 
immunosuppressive properties of UV radiation, and its underlying mechanisms is needed 
for the prevention and cure of skin cancer, but also for formulating therapeutic use of UV 
and future sun protection strategy.       
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